Precision immunosuppression as prevention and therapy for graft-versus-host disease
OwnerReka HARASZTI, Anastasia KREMERinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition, preferably a pharmaceutical composition for the prophylaxis and/or treatment of graft-versus-host disease (GvHD), a combination of inhibitory agents for use in the prophylaxis and/or treatment of GvHD, a stem cell comprising said composition or inhibitory agents, a method of producing said pharmaceutical composition, and to a method of prophylactical and/or therapeutical treatment of a subject suspected of having or developing GvHD.
Claims20
A method of prophylactical or therapeutical treatment of a subject suspected of having or developing graft-versus-host disease (GvHD) or having GvHD, comprising administering to the subject an inhibitor of RAs-related nuclear protein (RAN).
Dependencies are inferred from the claim text.